A Clinical Trial for the Evaluation of the Efficacy and Safety of MED-02 Probiotics on Reducing Body Fat
- Conditions
- Endocrine, nutritional and metabolic disease
- Registration Number
- KCT0005861
- Lead Sponsor
- Inje University Seoul Paik Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Age: 19-65
Body mass index: 25~32
A person who agrees to participate in this human application test and writes a written consent
Those who are currently being treated for severe cardiovascular, immune system, respiratory system, hepatobiliary system, kidney and urinary system, nervous system, musculoskeletal system, psychotic, infectious disease and malignant tumor
Those who use drugs that affect weight, health functional foods for weight control purposes, herbal medicines, or weight control formulas
Those who administered antibiotics within 2 weeks
Those who have consumed probiotics or lactobacillus products continuously within 2 weeks
Patients with uncontrolled hypertension
Diabetic patients with fasting blood sugar of 126 mg/dl or more or taking antidiabetic drugs
Those whose TSH is less than 0.1 uIU/ml or more than 10 uIU/ml
Those whose Creatinine is more than twice the normal upper limit
Those whose AST/ALT is more than 3 times the normal upper limit
Those who have problems in eating food for human application due to severe gastrointestinal disorders
People with alcohol use disorder and/or CNS disorder
Those who are judged to be unable to exercise due to musculoskeletal disorders
Those who have had a weight change of 10% or more within 3 months
Those who participated in a commercial obesity program within 3 months
Those who have participated in other interventional clinical trials within one month or plan to participate in other interventional clinical trials
Pregnant, nursing or planning to become pregnant
A person who judges that the tester is inappropriate for other reasons
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Body fat mass;body fat percentage
- Secondary Outcome Measures
Name Time Method Body weight, Waist circumference, Hip circumference, WHR, BMI, Lean body mass, Visceral fat area, Subcutaneous fat area, total abdominal fat area, VSR;Total cholesterol/HDL cholesterol/LDL cholesterol/Triglyceride/hs-CRP/Adiponectin/Leptin